Advances in biologic and small molecule therapies for hidradenitis suppurativa.

Chen, Stella X; Greif, Charlotte; Gibson, Ruby S; Porter, Martina L; Kimball, Alexa B

Chen, Stella X; Greif, Charlotte; Gibson, Ruby S; Porter, Martina L; Kimball, Alexa B.

Afiliação

Chen SX; Department of Dermatology, Massachusetts General Hospital, Harvard Combined Dermatology Residency Program, Boston, MA, USA.
Greif C; Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Gibson RS; Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Porter ML; Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Kimball AB; Department of Dermatology, Harvard Medical School, Boston, MA, USA.

Expert Opin Pharmacother ; 23(8): 959-978, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35470765

Assuntos

Produtos Biológicos; Hidradenite Supurativa; Adalimumab/uso terapêutico; Produtos Biológicos/uso terapêutico; Hidradenite Supurativa/tratamento farmacológico; Humanos; Pele

Palavras-chave

Hidradenitis; adalimumab; biologics; clinical; infliximab; inhibitors; molecule; small; suppurativa; therapies; trials

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Hidradenite Supurativa Limite: Humans Idioma: En Revista: Expert Opin Pharmacother Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google